Individual holder
GOLDSTEIN GLENN A
US·6 granted patents·12 pending applications·194 citations·filing 1987–2019
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
18 records- 0196US9216162B2N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2015·Granted Dec 22, 2015·13 cites·25 claims
- 0293US10869846B2N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2018·Granted Dec 22, 2020·5 cites·15 claims
- 0391US8937099B2N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2010·Granted Jan 20, 2015·15 cites·21 claims
- 0490US8354449B2N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2010·Granted Jan 15, 2013·14 cites·8 claims
- 0590US5240308AErgonomic adjustable chair and methodGOLDSTEIN GLENN A·Filed 1991·Granted Aug 31, 1993·95 cites·4 claims
- 0678US5018786AErgonomic adjustable chair and methodGOLDSTEIN GLENN A·Filed 1987·Granted May 28, 1991·52 cites·10 claims
- 0765US2017135970A1N-acetylcysteine amide (nac amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2016·Application pending·0 cites
- 0863US2016206576A1N-acetylcysteine amide (nac amide) in the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2015·Application pending·0 cites
- 0963US2020170968A1Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV InfectionGOLDSTEIN GLENN A·Filed 2019·Application pending·0 cites
- 1062US2020069617A1Use of n-acetylcysteine amide in the treatment of acetaminophen overdoseGOLDSTEIN GLENN A·Filed 2019·Application pending·0 cites
- 1159US2019151262A1Use of n-acetylcysteine amide for decreasing intracranial pressureGOLDSTEIN GLENN A·Filed 2018·Application pending·0 cites
- 1255US2009234011A1N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stressGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 1353US2008274888A1N-Acetylcysteine Amide (Nac Amide) for Enhancing Plant Resistance and Tolerance to Environmental StressGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 1453US2015133558A1Use of n-acetylcysteine amide for decreasing intracranial pressureGOLDSTEIN GLENN A·Filed 2014·Application pending·0 cites
- 1553US2017000747A1Use of n-acetylcysteine amide in the treatment of acetaminophen overdoseGOLDSTEIN GLENN A·Filed 2016·Application pending·0 cites
- 1651US2008200548A1N-Acetylcysteine Amide (Nac Amide) for Treatment of Oxidative Stress Associated with InfertilityGOLDSTEIN GLENN A·Filed 2006·Application pending·0 cites
- 1742US2010137676A1N-acetylcysteine amide (nac amide) for treatment of oxidative stress associated with infertilityGOLDSTEIN GLENN A·Filed 2010·Application pending·0 cites
- 1840US2017049727A1Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV InfectionGOLDSTEIN GLENN A·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GOLDSTEIN GLENN A files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →